Logo image of EKOP.BR

EKOPAK NV (EKOP.BR) Stock Fundamental Analysis

EBR:EKOP - Euronext Brussels - BE0974380124 - Common Stock - Currency: EUR

13.5  +0.15 (+1.12%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EKOP. EKOP was compared to 44 industry peers in the Commercial Services & Supplies industry. EKOP may be in some trouble as it scores bad on both profitability and health. EKOP shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

EKOP had negative earnings in the past year.
EKOP had a positive operating cash flow in the past year.
In the past 5 years EKOP reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: EKOP reported negative operating cash flow in multiple years.
EKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFEKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.20%, EKOP is doing worse than 73.17% of the companies in the same industry.
EKOP has a worse Return On Equity (-9.12%) than 68.29% of its industry peers.
Industry RankSector Rank
ROA -3.2%
ROE -9.12%
ROIC N/A
ROA(3y)-1.96%
ROA(5y)-0.86%
ROE(3y)-3.48%
ROE(5y)-1.29%
ROIC(3y)N/A
ROIC(5y)N/A
EKOP.BR Yearly ROA, ROE, ROICEKOP.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 100 150 200 250

1.3 Margins

Looking at the Gross Margin, with a value of 31.40%, EKOP is doing worse than 63.41% of the companies in the same industry.
EKOP's Gross Margin has declined in the last couple of years.
EKOP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.58%
GM growth 5Y-5.29%
EKOP.BR Yearly Profit, Operating, Gross MarginsEKOP.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

2

2. Health

2.1 Basic Checks

EKOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EKOP has about the same amount of shares outstanding.
EKOP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EKOP is higher compared to a year ago.
EKOP.BR Yearly Shares OutstandingEKOP.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M
EKOP.BR Yearly Total Debt VS Total AssetsEKOP.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.48, we must say that EKOP is in the distress zone and has some risk of bankruptcy.
EKOP's Altman-Z score of 1.48 is in line compared to the rest of the industry. EKOP outperforms 41.46% of its industry peers.
A Debt/Equity ratio of 0.95 indicates that EKOP is somewhat dependend on debt financing.
EKOP's Debt to Equity ratio of 0.95 is in line compared to the rest of the industry. EKOP outperforms 41.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z 1.48
ROIC/WACCN/A
WACC6.73%
EKOP.BR Yearly LT Debt VS Equity VS FCFEKOP.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

EKOP has a Current Ratio of 1.18. This is a normal value and indicates that EKOP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EKOP (1.18) is comparable to the rest of the industry.
A Quick Ratio of 0.96 indicates that EKOP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.96, EKOP is in line with its industry, outperforming 46.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.96
EKOP.BR Yearly Current Assets VS Current LiabilitesEKOP.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

7

3. Growth

3.1 Past

The earnings per share for EKOP have decreased strongly by -310.22% in the last year.
Looking at the last year, EKOP shows a very strong growth in Revenue. The Revenue has grown by 121.96%.
The Revenue has been growing by 40.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-310.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-826.59%
Revenue 1Y (TTM)121.96%
Revenue growth 3Y56.07%
Revenue growth 5Y40.37%
Sales Q2Q%128.57%

3.2 Future

Based on estimates for the next years, EKOP will show a very strong growth in Earnings Per Share. The EPS will grow by 75.07% on average per year.
EKOP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.77% yearly.
EPS Next Y-31.25%
EPS Next 2Y87.08%
EPS Next 3Y88.21%
EPS Next 5Y75.07%
Revenue Next Year71.16%
Revenue Next 2Y62.39%
Revenue Next 3Y46.4%
Revenue Next 5Y30.77%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EKOP.BR Yearly Revenue VS EstimatesEKOP.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EKOP.BR Yearly EPS VS EstimatesEKOP.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8 1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EKOP. In the last year negative earnings were reported.
EKOP is valuated quite expensively with a Price/Forward Earnings ratio of 110.29.
Based on the Price/Forward Earnings ratio, EKOP is valued a bit more expensive than 68.29% of the companies in the same industry.
EKOP is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 110.29
EKOP.BR Price Earnings VS Forward Price EarningsEKOP.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

68.29% of the companies in the same industry are cheaper than EKOP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 65.57
EKOP.BR Per share dataEKOP.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

EKOP's earnings are expected to grow with 88.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y87.08%
EPS Next 3Y88.21%

0

5. Dividend

5.1 Amount

No dividends for EKOP!.
Industry RankSector Rank
Dividend Yield N/A

EKOPAK NV

EBR:EKOP (2/4/2025, 7:00:00 PM)

13.5

+0.15 (+1.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.6%
Inst Owner ChangeN/A
Ins Owners78.53%
Ins Owner ChangeN/A
Market Cap200.07M
Analysts82.22
Price Target23.97 (77.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.08%
PT rev (3m)-2.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)21.25%
EPS NY rev (3m)21.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-10.42%
Revenue NY rev (3m)-10.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 110.29
P/S 3.68
P/FCF N/A
P/OCF 94.69
P/B 3.86
P/tB 378.2
EV/EBITDA 65.57
EPS(TTM)-0.32
EYN/A
EPS(NY)0.12
Fwd EY0.91%
FCF(TTM)-1.95
FCFYN/A
OCF(TTM)0.14
OCFY1.06%
SpS3.67
BVpS3.5
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.2%
ROE -9.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.4%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)-0.86%
ROE(3y)-3.48%
ROE(5y)-1.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.58%
GM growth 5Y-5.29%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Debt/EBITDA 12.77
Cap/Depr 364.09%
Cap/Sales 57.04%
Interest Coverage N/A
Cash Conversion 54.83%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 0.96
Altman-Z 1.48
F-Score3
WACC6.73%
ROIC/WACCN/A
Cap/Depr(3y)612.46%
Cap/Depr(5y)506.59%
Cap/Sales(3y)62.12%
Cap/Sales(5y)44.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-310.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-826.59%
EPS Next Y-31.25%
EPS Next 2Y87.08%
EPS Next 3Y88.21%
EPS Next 5Y75.07%
Revenue 1Y (TTM)121.96%
Revenue growth 3Y56.07%
Revenue growth 5Y40.37%
Sales Q2Q%128.57%
Revenue Next Year71.16%
Revenue Next 2Y62.39%
Revenue Next 3Y46.4%
Revenue Next 5Y30.77%
EBIT growth 1Y-231.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1377.78%
EBIT Next 3Y247.6%
EBIT Next 5Y134.81%
FCF growth 1Y-123.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.32%
OCF growth 3YN/A
OCF growth 5Y88.75%